Dry eye disease

Seminars in Ophthalmology

Volumn 25, Issue 3, 2010, Pages 84-93

  Pinho Tavares, Fabiana De ^a   Fernandes, Raphael Stehling ^a   Bernardes, Taliana Freitas ^b   Bonfioli, Adriana Alvim ^b   Carneiro Soares, Eduardo Jorge ^c  

^a Centro da Visão de Belo Horizonte   (Brazil)

^b Oftalmoclnica Rui Marinho   (Brazil)

^c Oculi   (Brazil)

Author keywords

Diagnosis; Dry eye; Review; Surgery; Treatment

Indexed keywords

12 SULFODEHYDROABIETIC ACID; CORTICOSTEROID; CYCLOSPORIN; DIQUAFOSOL; GEFARNATE; REBAMIPIDE; TETRACYCLINE;

ACUPUNCTURE; CONJUNCTIVA; DIET SUPPLEMENTATION; DRY EYE; EYE DISCOMFORT; HUMAN; PRIORITY JOURNAL; QUALITY OF LIFE; REVIEW; TEAR FILM; VISUAL DISORDER; DRY EYE SYNDROMES;

DRY EYE SYNDROMES; HUMANS;

EID: 77954219840     PISSN: 08820538     EISSN: 17445205     Source Type: Journal    
DOI: 10.3109/08820538.2010.488568     Document Type: Review

References (101)

1. Lemp, M.A. Report of the National Eye Institute/Industry workshop on Clinical Trials in Dry Eyes. CLAO J, 1995; 21(4): 221-232.
2. Lemp, M.A. The defnition and classifcation of dry eye disease: report of The Defnition and Classifcation Subcommittee of The International Dry Eye WorkShop (2007). Ocul Surf, 2007; 5(2):75-92.
3. Rolando, M., Zierhut, M. The ocular surface and tear flm and their dysfunction in dry eye disease. Surv Ophthalmol, 2001; 45 Suppl 2: S203-S210.
4. Abelson, M.B., Ousler, G.W. 3rd, Maffei, C. Dry eye in 2008. Curr Opin Ophthalmol, 2009; 20(4): 282-286.
5. Holly, F.J., Lemp, M.A. Tear physiology and dry eyes. Surv Ophthalmol, 1977; 22(2):69-87.
6. Lemp, M.A. Advances in understanding and managing dry eye disease. Am J Ophthalmol, 2008; 146(3): 350-356.
7. Stern, M.E., et al. The pathology of dry eye: the interaction between the ocular surface and lacrimal glands. Cornea, 1998; 17(6):584-589.
8. Perry, H.D. Dry eye disease: pathophysiology, classifca-tion, and diagnosis. Am J Manag Care, 2008; 14(3 Suppl): S79-S87.
9. Schaumberg, D.A., et al. Prevalence of dry eye disease among US men: estimates from the Physicians' Health Studies. Arch Ophthalmol, 2009; 127(6):763-768.
10. Schaumberg, D.A., et al. Prevalence of dry eye syndrome among US women. Am J Ophthalmol, 2003; 136(2): 318-326.
11. Smith, J.A. The epidemiology of dry eye disease: report of The Epidemiology Subcommittee of The International Dry Eye WorkShop (2007). Ocul Surf, 2007; 5(2):93-107.
12. Moss, S.E., Klein, R., Klein, B.E. Long-term incidence of dry eye in an older population. Optom Vis Sci, 2008; 85(8):668-674.
13. Brewitt, H. Sistani, F. Dry eye disease: the scale of the problem. Surv Ophthalmol, 2001; 45 Suppl 2:S199-S202.
14. Schiffman, R.M., et al. Utility assessment among patients with dry eye disease. Ophthalmology, 2003;110(7):1412-1419.
15. Schaumberg, D.A., et al. Hormone replacement therapy and dry eye syndrome. JAMA, 2001; 286(17):2114-2119.
16. Miljanovic, B., et al. Relation between dietary n-3 and n-6 fatty acids and clinically diagnosed dry eye syndrome in women. Am J Clin Nutr, 2005; 82(4):887-893.
17. Hovanesian, J.A., Shah, S.S., Maloney, R.K. Symptoms of dry eye and recurrent erosion syndrome after refractive surgery. J Cataract Refract Surg, 2001; 27(4):577-584.
18. Lee, W.B., et al. Ocular complications of hypovitaminosis a after bariatric surgery. Ophthalmology, 2005; 112(6):1031-1034.
19. Jaworowski, S., E., Drabkin, Y., Rozenman. Xerophthalmia and undiagnosed eating disorder. Psychosomatics, 2002; 43(6): 506-507.
20. Colev, M., et al. Vegan diet and vitamin A defciency. Clin Pediatr (Phila), 2004; 43(1):107-109.
21. Zegans, M.E., et al. Ocular manifestations of hepatitis C virus infection. Curr Opin Ophthalmol, 2002; 13(6):423-427.
22. Akinci, A., Cetinkaya, E., Aycan, Z. Dry eye syndrome in diabetic children. Eur J Ophthalmol, 2007; 17(6):873-878.
23. Kaiserman, I., et al. Dry eye in diabetic patients. Am J Oph-thalmol, 2005; 139(3):498-503.
24. Chronister, C.L. Review of external ocular disease associated with aids and HIV infection. Optom Vis Sci, 1996; 73(4): 225-230.
25. Merle, H., et al. Ocular manifestations in patients with HTLV-I associated infection-a clinical study of 93 cases. Jpn J Ophthalmol, 1996; 40(2): 260-270.
26. Aragona, P., et al. Utility of studying the ocular surface in patients with acne vulgaris treated with oral isotretinoin: a randomized controlled trial. Br J Dermatol, 2005; 152(3):576-578.
27. Ozdemir, M., et al. Ocular surface disorders and tear function changes in nodulo-cystic acne. J Dermatol, 2005; 32(3):174-178.
28. Xu, L., You, Q.S., Jonas, J.B. Prevalence of alcohol consumption and risk of ocular diseases in a general population: the Beijing Eye Study. Ophthalmology, 2009; 116(10):1872-1879.
29. Akinci, A., et al. Ocular fndings in children with chronic renal failure. Cornea, 2009; 28(1):5-6.
30. Hom, M., De Land, P. Prevalence and severity of symptomatic dry eyes in Hispanics. Optom Vis Sci, 2005; 82(3): 206-208.
31. Thomas, O., et al. Long-term complications of total body irradiation in adults. Int J Radiat Oncol Biol Phys, 2001; 49(1):125-131.
32. Bray, L.C., et al. Ocular complications of bone marrow transplantation. Br J Ophthalmol, 1991; 75(10):611-614.
33. Ogawa, Y. Kuwana. M. Dry eye as a major complication associated with chronic graft-versus-host disease after hematopoietic stem cell transplantation. Cornea, 2003; 22(7 Suppl):S19-S27.
34. Livesey, S.J., Holmes, J.A., Whittaker, J.A. Ocular complications of bone marrow transplantation. Eye (Lond), 1989; 3(Pt 3):271-276.
35. Franklin, R.M., et al. Ocular manifestations of graft-vs-host disease. Ophthalmology, 1983; 90(1):4-13.
36. Hirst, L.W., et al. The eye in bone marrow transplantation. I. Clinical study. Arch Ophthalmol, 1983; 101(4):580-584.
37. Cermak, J.M., et al. Is complete androgen insensitivity syndrome associated with alterations in the meibomian gland and ocular surface? Cornea, 2003; 22(6):516-521.
38. Sullivan, D.A., et al. Are women with Sjogren's syndrome androgen-defcient? J Rheumatol, 2003; 30(11):2413-2419.
39. Sullivan, D.A., et al. Do sex steroids exert sex-specifc and/or opposite effects on gene expression in lacrimal and mei-bomian glands? Mol Vis, 2009; 15:1553-1572.
40. Blehm, C., et al. Computer vision syndrome: a review. Surv Ophthalmol, 2005; 50(3):253-262.
41. Pritchard, N., Fonn, D., Brazeau, D. Discontinuation of contact lens wear: a survey. Int Contact Lens Clin, 1999; 26(6):157-162.
42. Richdale, K., et al. Frequency of and factors associated with contact lens dissatisfaction and discontinuation. Cornea, 2007; 26(2):168-174.
43. Quinto, G.G., Camacho, W., Behrens A. Postrefractive surgery dry eye. Curr Opin Ophthalmol, 2008; 19(4):335-341.
44. Toda, I. et al. Dry eye after laser in situ keratomileusis. Am J Ophthalmol, 2001; 132(1):1-7.
45. Linna, T.U., et al. Effect of myopic LASIK on corneal sensitivity and morphology of subbasal nerves. Invest Ophthalmol Vis Sci, 2000; 41(2):393-397.
46. Wilson, S.E. Laser in situ keratomileusis-induced (presumed) neurotrophic epitheliopathy. Ophthalmology, 2001; 108(6):1082-1087.
47. Rajan, M.S., et al. A long-term study of photorefractive keratectomy; 12-year follow-up. Ophthalmology, 2004; 111(10):1813-1824.
48. De Paiva, C.S., et al. The incidence and risk factors for developing dry eye after myopic LASIK. Am J Ophthalmol, 2006; 141(3):438-445.
49. Murube, J., et al. The triple classifcation of dry eye for practical clinical use. Eur J Ophthalmol, 2005; 15(6):660-667.
50. Jones, D.T., et al. Sjogren's syndrome: cytokine and Epstein-Barr viral gene expression within the conjunctival epithelium. Invest Ophthalmol Vis Sci, 1994; 35(9):3493-3504.
51. Tamer, C., et al. Tear flm tests in Parkinson's disease patients. Ophthalmology, 2005; 112(10):1795.
52. Li, D.Q., et al. Stimulation of matrix metalloproteinases by hyperosmolarity via a JNK pathway in human corneal epithelial cells. Invest Ophthalmol Vis Sci, 2004; 45(12):4302-4311.
53. Behrens, A., et al. Dysfunctional tear syndrome: a Delphi approach to treatment recommendations. Cornea, 2006; 25(8):900-907.
54. Schein, O.D., et al. Relation between signs and symptoms of dry eye in the elderly. A population-based perspective. Ophthalmology, 1997; 104(9): 1395-1401.
55. Bron, A.J., Smith, J.A., Calonge, M. Methodologies to diagnose and monitor dry eye disease: report of the Diagnostic Methodology Subcommittee of the International Dry Eye WorkShop (2007). Ocul Surf, 2007; 5(2):108-152.
56. Rapuano, C.J., Feder, R.S., Jones, M.R., et al. American Academy of Ophthalmology Preferred Practice Pattern, Guidelines. Dry Eye Syndrome. 2008 [cited 2008 September] Available from: http://www.aao.org/ppp.
57. Vitali, C., et al. Classifcation criteria for Sjogren's syndrome: a revised version of the European criteria proposed by the American-European Consensus Group. Ann Rheum Dis, 2002; 61(6):554-558.
58. Nichols, K.K., Nichols, J.J., Mitchell, G.L. The reliability and validity of McMonnies Dry Eye Index. Cornea, 2004; 23(4):365-371.
59. Doughty, M.J., et al. A patient questionnaire approach to estimating the prevalence of dry eye symptoms in patients presenting to optometric practices across Canada. Optom Vis Sci, 1997; 74(8):624-631.
60. Schiffman, R.M., et al. Reliability and validity of the Ocular Surface Disease Index. Arch Ophthalmol, 2000; 118(5):615-621.
61. Begley, C.G., et al. Use of the dry eye questionnaire to measure symptoms of ocular irritation in patients with aqueous tear defcient dry eye. Cornea, 2002; 21(7):664-670.
62. Rajagopalan, K., et al. Comparing the discriminative validity of two generic and one disease-specifc health-related quality of life measures in a sample of patients with dry eye. Value Health, 2005; 8(2):168-174.
63. Bron, A.J. Diagnosis of dry eye. Surv Ophthalmol, 2001; 45 Suppl 2:S221-S226.
64. Barr, J.T., et al. Corneal scarring in the Collaborative Longitudinal Evaluation of Keratoconus (CLEK) Study: baseline prevalence and repeatability of detection. Cornea, 1999; 18(1):34-46.
65. Bron, A.J., Evans, V.E., Smith, J.A. Grading of corneal and conjunctival staining in the context of other dry eye tests. Cornea, 2003; 22(7):640-650.
66. Lemp, M.A., Hamill, J.R., Jr. Factors affecting tear flm breakup in normal eyes. Arch Ophthalmol, 1973; 89(2):103-105.
67. Johnson, M.E., Murphy, P.J. The effect of instilled fuorescein solution volume on the values and repeatability of TBUT measurements. Cornea, 2005; 24(7):811-817.
68. Abelson, M.B., et al. Alternative reference values for tear flm break up time in normal and dry eye populations. Adv Exp Med Biol, 2002; 506(Pt B):1121-1125.
69. Mengher, L.S., et al. A non-invasive instrument for clinical assessment of the pre-corneal tear flm stability. Curr Eye Res, 1985; 4(1):1-7.
70. van Bijsterveld, O.P. Diagnostic tests in the Sicca syndrome. Arch Ophthalmol, 1969; 82(1):10-14.
71. Farris, R.L., Stuchell, R.N., Mandel, I.D. Basal and refex human tear analysis. I. Physical measurements: osmolarity, basal volumes, and refex fow rate. Ophthalmology, 1981; 88(8):852-857.
72. Farris, R.L. Tear osmolarity-a new gold standard? Adv Exp Med Biol, 1994; 350:495-503.
73. Pfugfelder, S.C. Management and therapy of dry eye disease: report of the Management and Therapy Subcommittee of the International Dry Eye WorkShop (2007). Ocul Surf, 2007; 5(2):163-178.
74. Calonge, M. The treatment of dry eye. Surv Ophthalmol, 2001; 45 Suppl 2: S227-S239.
75. Gasset, A.R. et al. Cytotoxicity of ophthalmic preservatives. Am J Ophthalmol, 1974; 78(1):98-105.
76. Burstein, N.L. Corneal cytotoxicity of topically applied drugs, vehicles and preservatives. Surv Ophthalmol, 1980; 25(1):15-30.
77. nd. Adverse external ocular effects of topical ophthalmic medications. Surv Ophthalmol, 1979; 24(2):57-88.
78. Yoon, K.C., et al. Comparison of autologous serum and umbilical cord serum eye drops for dry eye syndrome. Am J Ophthalmol, 2007; 144(1):86-92.
79. Stevenson, D., Tauber, J., Reis, B.L. Effcacy and safety of cyclosporin A ophthalmic emulsion in the treatment of moderate-to-severe dry eye disease: a dose-ranging, randomized trial. The Cyclosporin A Phase 2 Study Group. Ophthalmology, 2000; 107(5):967-974.
80. Sall, K., et al. Two multicenter, randomized studies of the effcacy and safety of cyclosporine ophthalmic emulsion in moderate to severe dry eye disease. CsA Phase 3 Study Group. Ophthalmology, 2000; 107(4):631-639.
81. Marsh, P., Pfugfelder, S.C. Topical nonpreserved meth-ylprednisolone therapy for keratoconjunctivitis sicca in Sjogren syndrome. Ophthalmology, 1999; 106(4):811-816.
82. Roncone, M., Bartlett, H., Eperjesi, F. Essential fatty acids for dry eye: A review. Cont Lens Anterior Eye, 2010; 33(2):49-54.
83. Rosenberg, E.S., Asbell, P.A. Essential fatty acids in the treatment of dry eye. Ocul Surf, 2010; 8(1):18-28.
84. Rashid, S., et al. Topical omega-3 and omega-6 fatty acids for treatment of dry eye. Arch Ophthalmol, 2008; 126(2):219-225.
85. Kim, E.C., Choi, J.S., Joo, C.K. A comparison of vitamin a and cyclosporine a 0.05% eye drops for treatment of dry eye syndrome. Am J Ophthalmol, 2009; 147(2):206-213 e3.
86. Johnson, L.N. Pilot Study of a Homeopathic Therapy in Combination With Cyclosporin (Restasis) in the Treatment of Dry Eye Disease. 2007 [cited 2010 February]; available from: http://clinicaltrials.gov/ct2/show/NCT01072526.
87. Kim, T.H., et al. Acupuncture for dry eye: a randomised controlled trial protocol. Trials, 2009; 10:112.
88. Baxter, S.A., Laibson, P.R. Punctal plugs in the management of dry eyes. Ocul Surf, 2004; 2(4):255-265.
89. Hamano, T. Lacrimal duct occlusion for the treatment of dry eye. Semin Ophthalmol, 2005; 20(2):71-74.
90. Kaido, M. et al. A new punctal plug insertion technique to prevent intracanalicular plug migration. Am J Ophthalmol, 2009; 147(1):178-182 e1.
91. Miyata, K., et al. Atelocollagen punctal occlusion in dry eye patients. Cornea, 2006; 25(1):47-50.
92. Filatov, V.P., C.V. Untitled letter. J Ophthalmol (Odessa), 1951; 55:893-894.
93. Murube, J., M.G., Marcos, Javate, R. Amylase in mare lacri-male in patients with submandibular salivary gland transplantation to the lacrimal basin. Adv Exp Med Biol, 1994; 350:565-570.
94. Geerling, G., et al. Transplantation of the autologous sub-mandibular gland for most severe cases of keratoconjuncti-vitis sicca. Ophthalmology, 1998; 105(2):327-335.
95. Sieg, P., et al. Microvascular submandibular gland transfer for severe cases of keratoconjunctivitis sicca. Plast Reconstr Surg, 2000; 106(3):554-60; discussion 561-562.
96. Guerrissi, J.O. Belmonte, J. Surgical treatment of dry eye syndrome: conjunctival graft of the minor salivary gland. J Craniofac Surg, 2004; 15(1): p. 6-10.
97. Murube, J. Labial salivary gland transplantation in severe dry eye. Oculoplast Orbital Reconstr Surg, 1998; 1:104-110.
98. Raus, P. Radiosurgery aids in salivary gland transplants for severe dry eye. Ocular Surg News, 2003; 12:15-16.
99. Soares, E.J., Franca, V.P. Transplantation of labial salivary glands for severe dry eye treatment. Arq Bras Oftalmol, 2005; 68(4):481-489.
100. Murube, J., et al. Subcutaneous abdominal artifcial tears pump-reservoir for severe dry eye. Orbit, 2003; 22(1):29-40.
101. Geerling, G. Borrelli, M. Adnexal surgery for severe ocular surface disease. Semin Ophthalmol, 2005; 20(2):101-112.